Pacira BioSciences Operating Cycle Over Time
| PCRX Stock | USD 21.00 0.64 3.14% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Pacira BioSciences Performance and Pacira BioSciences Correlation. Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pacira BioSciences. Anticipated expansion of Pacira directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Pacira BioSciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.48) | Earnings Share 0.47 | Revenue Per Share | Quarterly Revenue Growth 0.065 | Return On Assets |
Understanding Pacira BioSciences requires distinguishing between market price and book value, where the latter reflects Pacira's accounting equity. The concept of intrinsic value - what Pacira BioSciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Pacira BioSciences' price substantially above or below its fundamental value.
It's important to distinguish between Pacira BioSciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Pacira BioSciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Pacira BioSciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cross Equities Operating Cycle Analysis
Compare Pacira BioSciences and related stocks such as Cronos Group, AnaptysBio, and Xencor Inc Operating Cycle Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CRON | (104) | (104) | (104) | (104) | (104) | (54.9513) | 1 K | 2.4 K | 1.1 K | 605 | 426 | 337 | 348 | 299 | 231 | 266 | 253 |
| ANAB | 33.5317 | 33.5317 | 33.5317 | 33.5317 | 33.5317 | 25.4675 | 117 | 58.4365 | 12.702 | 5.0612 | 5.0612 | 5.0612 | 50.3485 | 146 | 163 | 147 | 154 |
| XNCR | 1.5455 | 1.5455 | 13.5668 | 0.8503 | 55.2496 | 0.1081 | 35.9328 | 11.6723 | 91.5759 | 57.7105 | 71.2276 | 88.0741 | 64.309 | 23.5996 | 201 | 181 | 190 |
| OCS | 413 | 413 | 413 | 413 | 413 | 413 | 413 | 413 | 413 | 413 | 413 | 413 | 413 | 413 | 413 | 372 | 331 |
| URGN | 1.4 K | 1.4 K | 1.4 K | 1.4 K | 1.4 K | 1.4 K | 1.4 K | 192 | 928 | 928 | 928 | 431 | 278 | 289 | 461 | 530 | 621 |
| KOD | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| TNDM | 957 | 957 | 957 | 232 | 182 | 209 | 176 | 226 | 147 | 153 | 158 | 134 | 157 | 203 | 166 | 191 | 262 |
| BBOT | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| PHAT | (99.7667) | (99.7667) | (99.7667) | (99.7667) | (99.7667) | (99.7667) | (99.7667) | (99.7667) | (99.7667) | (99.7667) | (99.7667) | 3.5 K | 3.5 K | 3.5 K | 403 | 363 | 345 |
Pacira BioSciences and related stocks such as Cronos Group, AnaptysBio, and Xencor Inc Operating Cycle description
My Equities
My Current Equities and Potential Positions
| Pacira BioSciences | PCRX |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 2000 Sierra Point |
| Exchange | NASDAQ Exchange |
USD 21.0
Additional Tools for Pacira Stock Analysis
When running Pacira BioSciences' price analysis, check to measure Pacira BioSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira BioSciences is operating at the current time. Most of Pacira BioSciences' value examination focuses on studying past and present price action to predict the probability of Pacira BioSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira BioSciences' price. Additionally, you may evaluate how the addition of Pacira BioSciences to your portfolios can decrease your overall portfolio volatility.